Get started
Author

Joost C.H. van Oostrom

Observed names: J C van Oostrom, J van Oostrom, J. C. H. van Oostrom, J. van Oostrom, J.C.H. Oostrom, J.C.H. Van Oostrom, J.C.H. van Oostrom, Joost C H van Oostrom, Joost C. H. van Oostrom, Joost CH van Oostrom, Joost van Oostrom, van Oostrom JC
Observed institutions: Leiden University, University Medical Center Groningen, University of Groningen, Leiden University Medical Center, Medisch Spectrum Twente, St. Antonius Ziekenhuis, Amsterdam University Medical Centers, Cardiff University
OpenAlex ID: A5111823558
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
2005 · Rudie Kortekaas, Klaus L. Leenders, et al. · Annals of Neurology · 732
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
2012 · J.-M. Lee, E.M. Ramos, et al. · Neurology · 382
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 311
PDF
Typical cerebral metabolic patterns in neurodegenerative brain diseases
2010 · Laura K. Teune, Anna L. Bartels, et al. · Movement Disorders · 267
Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA
2008 · A. L. Bartels, A. T. M. Willemsen, et al. · Journal of Neural Transmission · 258
PDF
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial
2010 · Ivo N van Schaik, Filip Eftimov, et al. · The Lancet Neurology · 219
Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
2008 · Anna L. Bartels, Rudie Kortekaas, et al. · Neurobiology of Aging · 158
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
2021 · Christa Walgaard, Bart C Jacobs, et al. · The Lancet Neurology · 123
PDF
Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment
2012 · F. Eftimov, M. Vermeulen, et al. · Neurology · 122
Metabolic network as a progression biomarker of premanifest Huntington’s disease
2013 · Chris C. Tang, Andrew Feigin, et al. · Journal of Clinical Investigation · 120
Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease
2005 · J.C.H. van Oostrom, R. P. Maguire, et al. · Neurology · 90
Changes in striatal dopamine D2 receptor binding in pre‐clinical Huntington’s disease
2008 · J.C.H. Van Oostrom, M. Dekker, et al. · European Journal of Neurology · 68
1H magnetic resonance spectroscopy in preclinical Huntington disease
2007 · Joost C.H. van Oostrom, Paul E. Sijens, et al. · Brain Research · 36
Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study
2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 35
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington’s disease
2014 · Meike Herben-Dekker, Joost C. H. van Oostrom, et al. · Journal of Neurology · 31
Hashimoto encephalopathy in a 12-year-old girl
1999 · C. A. Sybesma, E. v. Pinxteren-Nagler, et al. · European Journal of Pediatrics · 20
[Variable manifestations of Hashimoto's encephalopathy].
1999 · J C van Oostrom, A Schaafsma, et al. · PubMed · 8
The Syndrome of Headache with Neurologic Deficits and Cerebrospinal Fluid Lymphocytosis Mimicking Acute Ischemic Stroke
2008 · Marcel J.H. Ariës, Joost C.H. van Oostrom, et al. · Journal of Stroke and Cerebrovascular Diseases · 7
P401 Tofacitinib tissue exposure correlates with endoscopic outcome
2022 · B Verstockt, D Alsoud, et al. · Journal of Crohn s and Colitis · 5
Biomarkers in premanifest Huntington's disease
2015 · Joost C.H. van Oostrom · University of Groningen research database (University of Groningen / Centre for Information Technology)
[Cerebellar dysfunction due to pneumonia caused by Legionella pneumophila].
2013 · Matthijs Kramer, Joost C H van Oostrom, et al. · PubMed
Cognition in relation to metabolic changes in the brain of preclinical mutation carriers of Huntington's disease
2008 · Mirthe Dekker, J. van Oostrom, et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
Changes in striatal dopamine D2 receptor binding in preclinical Huntington's disease
2008 · J. van Oostrom, M. Dekker, et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
G.P.10.13 Genotype-phenotype correlations for the skeletal muscle chloride- and sodium-channelopathies
2007 · J. Trip, G. Drost, et al. · Neuromuscular Disorders
Contacting Huntington carriers and non-carriers for research purposes after presymptomatic testing.
2001 · CC Verschuuren, E. H. Sikkens, et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
Works count: 27
Citation count: 2,992
H-index: 16
I10-index: 16
Year
Topic
Type